- $316.63m
- -$374.11m
- CNY4.20bn
- 66
- 66
- 57
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 671 | 1,352 | 2,959 | 3,605 | 4,199 |
Cost of Revenue | |||||
Gross Profit | 312 | 758 | 1,554 | 1,808 | 2,296 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 1,729 | 1,955 | 4,350 | 5,209 | 5,271 |
Operating Profit | -1,058 | -603 | -1,391 | -1,604 | -1,072 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1,004 | -516 | -1,293 | -1,564 | -828 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1,004 | -518 | -1,299 | -1,578 | -840 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1,004 | -518 | -1,299 | -1,581 | -844 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1,431 | -1,198 | -1,469 | -1,581 | -844 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -5.1 | -4.27 | -6.12 | -5.19 | -2.82 |
Dividends per Share |